21 May 2013
Keywords: temodal, receives, eu, marketing, authorization, commonest, most
Article | 02 February 1999
The commonest and most deadly form of malignant glioma, glioblastomamultiforme, has a new enemy in the European Union after marketing
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
4 February 1999
27 January 1999
20 May 2013
© 2013 thepharmaletter.com